Company Filing History:
1 out of 15 
1 out of 4 
1 out of 30 Years Active: 2020
Title: The Innovations of Jesús Egido De Los Rios
Introduction
Jesús Egido De Los Rios is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medical research, particularly in the area of diabetes complications. His work focuses on innovative solutions that address chronic health issues.
Latest Patents
One of his key patents is the "SOCS1-derived peptide for use in chronic complications of diabetes." This invention relates to a SOCS1-derived peptide that targets chronic complications associated with diabetes, including ocular, renal, nerve, and vascular complications. The patent also covers compositions containing this peptide and isolated polynucleotides encoding it. Furthermore, the SOCS1-derived peptide is intended for topical use in treating and preventing neurodegenerative diseases of the retina, especially in the early stages of diabetic retinopathy.
Career Highlights
Throughout his career, Jesús has worked with prominent institutions such as Fundació Hospital Universitari Vall D'Hebron - Institut De Recerca and Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz. His research has been instrumental in advancing the understanding and treatment of diabetes-related complications.
Collaborations
Some of his notable coworkers include Carmen Gómez Guerrero and Rafael Simó Canonge. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Jesús Egido De Los Rios exemplifies the spirit of innovation in medical research. His contributions, particularly in the realm of diabetes complications, highlight the importance of continued research and development in healthcare.